Dan Pompa, a leading functional medicine expert, the conversation focused on a pressing issue that many people face: low energy and constant fatigue
NAFLD is primarily associated with metabolic risk factors, such as obesity, type 2 diabetes, high cholesterol, and metabolic syndrome
This means that in terms of pure metabolic correction, moderate dosing was already delivering much of the effect, while higher doses primarily amplified weight loss outcomes
Most people achieve 20-30 pounds of weight loss over 12-18 months on cagrilintide alone, with combination therapy producing 40-60+ pounds lost
L-cysteine is the rate-limiting substrate in the synthesis of intracellular GSH (Raftos et al., 2007